Navigation Links
Metabolomx Awarded $1.14 Million SBIR Grant from National Cancer Institute for Breath Analysis Test of Lung Cancer
Date:10/24/2011

MOUNTAIN VIEW, Calif., Oct. 24, 2011 /PRNewswire/ -- Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.

Metabolomx' proprietary technology is designed to recognize the molecular fingerprint of lung cancer via a sampling of metabolites (volatile organic compounds) in exhaled breath. The Company's system currently is being evaluated in a large lung cancer screening study at the Cleveland Clinic.

Paul Rhodes, Ph.D., Founder and CEO of Metabolomx, commented, "The core insight of Metabolomx is that the pattern of small-molecule metabolites produced by active tumors can be observed in exhaled breath. Because our system is rapid, non-invasive and inexpensive, we believe it can be both a timely adjunct diagnostic following an indeterminate CT scan and, in the future, can help facilitate earlier diagnosis of disease. This is particularly critical in lung cancer, since many patients are first diagnosed only late in their disease."

Dr. Rhodes continued, "We are grateful for the support of the NCI grant, which will help us to further validate our technology and advance the breakthrough studies of our breath analysis system for lung cancer, breast cancer, colon cancer and other cancers."

About Metabolomx

Metabolomx has developed and owns all worldwide rights to the foremost breath test for cancer. By engaging some of the brightest minds in the fields of artificial and biological olfactory sensor arrays, neural processing and product development, Metabolomx has developed and tested an artificial olfactory sensor technology that recognizes the molecular fingerprint of the disease signature in breath. Metabolomx' technology is enabling the non-invasive, rapid, inexpensive and early diagnosis of lung cancer and other cancers. Metabolomx is located in Mountain View, CA. For additional information on the Company, please visit www.metabolomx.com.

Contacts

Media              
Justin Jackson              
Michelle Szwarcberg              
Burns McClellan              
Tel: +1-212-213-0006              
Email: jjackson@burnsmc.com                
mszwarcberg@burnsmc.com


'/>"/>
SOURCE Metabolomx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
2. Dr. Yong Shi awarded NSF grant
3. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
4. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
5. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
6. GeneGo Is Awarded NCI Grant for Development of Systems Biology Database and Tools for Nutrition in Cancer in Collaboration with the FDA
7. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
8. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
9. Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
10. Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses
11. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced the ... NIH to develop RealSeq®-SC (Single Cell), expected to be ... small RNAs (including microRNAs) from single cells using NGS ... the need to accelerate development of approaches to analyze ... "New techniques for measuring levels of mRNAs ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... recipients of 13 prestigious awards honoring scientists who have made ... in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series ... 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population ... challenge of how to continue to feed a growing nation. At the same time, ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):